NavPoint are supporting cancer care at The Ottawa Hospital
For the fourth consecutive year, NavPoint will continue to support the new Molecular Oncology Diagnostics Laboratory (MODL) at The Ottawa Hospital.
With the help of NavPoint employees, the new Molecular Oncology Diagnostics Lab will bring an end to the one-size-fits-all tradition of cancer treatment. This new Lab will bring our diagnostic abilities to a higher level – a 21st century level. It will help doctors to provide personalized treatment plans for each individual patient, as well as allow for timelier testing. Molecular diagnostics, along with our commitment to groundbreaking cancer research, state-of-the-art facilities at the Cancer Centre and leading edge surgical procedures, will mean cancer patients at The Ottawa Hospital will have access to the most progressive and effective cancer treatment possible.
Thank you, NavPoint team, for your continued support. Your generosity is making a difference in patient care and cancer treatment in our region!